FibroBiologics, Inc.
Clinical-stage biotech developing fibroblast cell therapies for chronic diseases.
FBLG | NDAQ
Overview
Corporate Details
- ISIN(s):
- US31573L1052
- LEI:
- Country:
- United States of America
- Address:
- 455 E. MEDICAL CENTER BLVD, 77598 HOUSTON
- Website:
- https://fibrobiologics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
FibroBiologics, Inc. is a clinical-stage biotechnology company developing fibroblast cell-based therapies to treat and potentially cure chronic diseases. The company's core technology is centered on using fibroblasts, which it posits as a more effective, practical, and economical alternative to stem cells for tissue regeneration and immune modulation. Its development pipeline targets a range of conditions, including multiple sclerosis, degenerative disc disease, wound healing, and age-related organ decline. FibroBiologics supports its therapeutic platform with an extensive intellectual property portfolio of over 150 patents, aiming to address significant unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all FibroBiologics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for FibroBiologics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for FibroBiologics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}
